Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action

Journal of Psychiatric Research

Volumn 38, Issue 3, 2004, Pages 237-240

  Krahl, Scott E ^a,b   Senanayake, Shayani S ^a   Pekary, A Eugene ^a,b   Sattin, Albert ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressant; Depression; Desipramine; Electroconvulsant shock (ECS); Forced swim test (FST); Vagus nerve stimulation (VNS)

Indexed keywords

DESIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; ELECTRIC SHOCK; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION; TASK PERFORMANCE; TREATMENT OUTCOME; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 1542315615     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2003.11.005     Document Type: Article

References (18)

1. DiCarlo S.E., Collins H.L., Chen C.Y. Vagal afferents reflexly inhibit exercise in conscious rats. Medicine and Science in Sports and Exercise. 26:1994;459-462.
2. Handforth A., DeGiorgio C.M., Schachter S.C., Uthman B.M., Naritoku D.K., Tecoma E.S.et al. Vagus nerve stimulation therapy for partial-onset seizures. a randomized active-control trial Neurology. 51:1998;48-55.
3. Handforth A., Krahl S.E. Suppression of harmaline-induced tremor in rats by vagus nerve stimulation. Movement Disorders. 16:2001;84-88.
4. Kirby L.G., Lucki I. Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. Journal of Pharmacology and Experimental Therapeutics. 282:1997;967-976.
5. Krahl S.E., Clark K.B., Smith D.C., Browning R.A. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia. 39:1998;709-714.
6. Krahl S.E., Pekary A.E., Senanayake S.S., Sattin A. Antidepressant efficacy of vagus nerve stimulation. World Journal of Biological Psychiatry. 2(Suppl. 1):2001;336S.
7. Krahl S.E., Pekary A.E., Senanayake S.S., Sattin A. Vagus nerve stimulation is an effective antidepressant treatment in an animal model of depression. Society for Neuroscience Abstracts. 2001;26.
8. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behavioural Pharmacology. 8:1997;523-532.
9. Pare W.P. Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats. Physiology and Behavior. 55:1994;433-439.
10. Pare W.P. Stress ulcer susceptibility and depression in Wistar Kyoto WKY rats. Physiology and Behavior. 46:1989;938-993.
11. Petty F., Davis L.L., Kabel D., Kramer G.L. Serotonin dysfunction disorders. a behavioral neurochemistry perspective Journal of Clinical Psychiatry. 57(Suppl. 8):1996;11-16.
12. Pickar J.G., Hill J.M., Kaufman M.P. Stimulation of vagal afferents inhibits locomotion in mesencephalic cats. Journal of Applied Physiology. 74:1993;103-110.
13. Porsolt R.D., Le Pichon M., Jalfre M. Depression. a new animal model sensitive to antidepressant treatments Nature. 266:1977;730-732.
14. Porsolt R.D., Anton G., Deniel M., Jalfre M. Behavioral despair in rats. a new model sensitive to antidepressant treatments European Journal of Pharmacology. 47:1978;379-391.
15. Rawlins P. Are there benefits, in addition to improved seizure control, for children receiving vagus nerve stimulation? Epilepsia. 38(Supp. 8):1997;155-156.
16. Rush A.J., George M.S., Sackeim H.A., Marangell L.B., Husain M.M., Giller C., Nahas Z.et al. Vagus nerve stimulation VNS for treatment-resistant depressions. a multicenter study Biological Psychiatry. 47:2000;273-275.
17. Sattin A., Pekary A.E., Lloyd R.L. TRH gene products are implicated in the antidepressant mechanisms of seizures. Annals of the New York Academy of Sciences. 738:1994;135-153.
18. Uthman B.M., Wilder B.J., Hammond E.J., Reid S.A. Efficacy and safety of vagus nerve stimulation in patients with complex partial seizures. Epilepsia. 31(Supp. 2):1990;44-50.